Antirheumatoid second-line drugs and mucosal injury by NSAIDs

Comment

M Guslandi. Am J Gastroenterol. 1992 Oct.

. 1992 Oct;87(10):1526-7.

No abstract available

Comment on

Nonsteroidal peptic damage in rheumatoid patients receiving second-line drugs.
Taha AS, Capell HA, Sturrock RD, Russell RI. Taha AS, et al. Am J Gastroenterol. 1991 Nov;86(11):1588-91. Am J Gastroenterol. 1991. PMID: 1683150

Efficacy of misoprostol in upper gastro-intestinal lesions in arthritic patients on non-steroidal anti-inflammatory drugs (NSAIDS)--an Indian experience.
Bhatt CB, Pipalia DH, Naik SR, Tilve GH. Bhatt CB, et al. J Postgrad Med. 1988 Oct;34(4):224-8. J Postgrad Med. 1988. PMID: 3151214 No abstract available.
Famotidine to prevent peptic ulcer caused by NSAIDs.
Singh G, Fries JF. Singh G, et al. N Engl J Med. 1996 Oct 24;335(17):1322; author reply 1322-3. N Engl J Med. 1996. PMID: 8992334 No abstract available.
Pathogenesis of peptic ulcer in rheumatoid arthritis.
Tuteja AK, Malviya AN, Bannerjee S, Singh RR, Anand BS. Tuteja AK, et al. J Assoc Physicians India. 1991 Jul;39(7):521-2. J Assoc Physicians India. 1991. PMID: 1800492
Musculoskeletal disorders. Non-steroidal anti-inflammatory drugs.
Gøtzsche PC. Gøtzsche PC. Clin Evid. 2003 Jun;(9):1292-300. Clin Evid. 2003. Update in: Clin Evid. 2004 Jun;(11):1551-9. PMID: 12967421 Updated. Review. No abstract available.
[Preferential COX-2 inhibition: its clinical relevance for gastrointestinal non-steroidal anti-inflammatory rheumatic drug toxicity].
Dammann HG. Dammann HG. Z Gastroenterol. 1999 Jan;37(1):45-58. Z Gastroenterol. 1999. PMID: 10091284 Review. German.